ClinicalTrials.Veeva

Menu

the Application of Diffusion Tensor Imaging in the Evaluation of Peripheral Neuropathy in ANCA Associated Vasculitis

Zhejiang University logo

Zhejiang University

Status

Unknown

Conditions

ANCA Associated Vasculitis

Treatments

Other: diffusion tensor imaging(DTI) evaluation

Study type

Observational

Funder types

Other

Identifiers

NCT04923074
2020-162

Details and patient eligibility

About

  1. Include qualified 50 ANCA-associated vasculitis(AAV) patients; and the first 27 patients will be divided into 3 groups with different diffused tension image (DTI) parameters and to choose the best strategy;
  2. On baseline, 6 months after treatment and 24 months after treatment, the AAV patients will accomplish the Birming-ham vasculitis activity score(BVAS) besides DTI;
  3. The new serum biomarkers of AAV associated peripheral neuropathy will be measured by ELISA; (4) Another cohort with 50 patients with AAV associated peripheral neuropathy who were evaluated by traditional methods (electromyogram) and compared to the patients cohort that evaluated using DTI by cost-benefit analysis

Enrollment

50 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age between 18-80 years old;
  • must fulfill 2012 criteria of ANCA associated vasculitis
  • presented with peripheral neuropathy diagnosed by specialists

Exclusion criteria

  • the ANCA associated vasculitis is already in the stable stage after treatments
  • any vital organ dysfunction
  • active infection or cancer
  • can not finish DTI scan

Trial design

50 participants in 2 patient groups

DTI group
Description:
the patient in this group will receive DTI evaluation
Treatment:
Other: diffusion tensor imaging(DTI) evaluation
routine group
Description:
the patient in this group will receive routine evaluation

Trial contacts and locations

1

Loading...

Central trial contact

ting zhang; wenjia sun

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems